StockData
Precision BioSciences Inc logo

Precision BioSciences Inc (DTIL) stock

DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3058% above fair value
$7.05−0.23 (-3.16%)

Close on Nov 17, 2026Market cap $194.59MP/E –Yield –

Earnings

Precision BioSciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 11, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
–
– on a year earlier
EPS, Q3 FY2026
-$0.28
-$1.84 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Precision BioSciences's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 11, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 3, 2026before the open––-$0.28Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026before the open$0–-$1.26Release
Q1 FY2026ended Mar 31, 2026May 5, 2026before the open$10.80M+37141.4%-$0.75Release
Q4 FY2025ended Dec 31, 2025Mar 12, 2026before the open$34.20M+5600.0%$1.05Release
Q3 FY2025ended Sep 30, 2025Nov 3, 2025before the open$100.00K-83.3%-$1.84Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025before the open––-$2.13Release
Q1 FY2025ended Mar 31, 2025May 15, 2025before the open$29.00K-99.8%-$2.21Release
Q4 FY2024ended Dec 31, 2024Mar 26, 2025before the open$600.00K-91.4%-$2.22Release
Q3 FY2024ended Sep 30, 2024Nov 4, 2024before the open$600.00K-95.4%-$2.25Release
Q2 FY2024ended Jun 30, 2024Aug 1, 2024before the open$49.90M+152.0%$4.67Release
Q1 FY2024ended Mar 31, 2024May 13, 2024before the open$17.60M+100.0%$1.70Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Precision BioSciences has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Precision BioSciences puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Precision BioSciences filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. Update
  3. Update
  4. Update
  5. Results
  6. Update
  7. Results
  8. Update
  9. Update
  10. Results
  11. Update
  12. Results
  13. Update
  14. Results
  15. News

See a number that looks wrong?